Vnitr Lek 1996, 42(10):693-695

[Interferon in the treatment of Loeffler's endocarditis].

J Pella, R Rybár, D Pella, D Trejbal: III. interná klinika FN L. Pasteurs, Kosice.

Klíčová slova: Female; Humans; Hypereosinophilic Syndrome, therapy, ; Interferon Type I, therapeutic use, ; Middle Aged; Recombinant Proteins

The authors describe their own experience with the administration of recombinant alpha 2c interferon in the treatment of Loefller's endocarditis. Based on their analysis (as well as in keeping with the spares data in the literature-as a rare disease is involved), the authors consider this procedure as a qualitative advance of treatment. They consider their account as preliminary because of the short period of time, and therefore in future strict dispensary care of the patient is essential.